This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Vertex Pharmaceuticals Incorporated
Drug Names(s): VX150, VX 150
Description: VX-150 is a proprietary compound designed to block pain signaling through inhibition of a sodium channel known as NaV 1.8.
Additional information available to subscribers only: